iSpecimen Inc.

ISPC Healthcare Diagnostics & Research

iSpecimen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 79.2% from fiscal 2024. In the quarter to June 2026, revenue fell 78.7%, EPS grew 94.2% and free cash flow fell 257.7%, each against the same quarter a year earlier.

0.92 0.11 −10.68%
Market cap
$2.6M
P/E
0.0×
Fwd P/E
−0.3×
Dividend yield
—
F-score
3/9
Altman Z
−14.80
Beneish M
10.08
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 7 2 4 3 3 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — 2.71 (1.24) (6.34) (14.35) (14.80)
P/S ratio
— 0.73 0.73 0.73 3.03 1.20 0.48 0.20 0.62
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— (42.51) (47.90) (38.33) 6.28 (0.12) (14.39) (35.16) (33.49)
P/Operating CF
— (54.39) (54.39) (54.39) (25.57) (60.40) 13.75 (0.53) (1.31)
Beneish M-Score
— — (4.32) (5.03) (1.52) (2.95) (4.09) (5.11) 10.08
P/B ratio
— 0.00 0.00 0.00 1.13 0.62 0.49 0.57 0.39
EV/Sales
— 1.87 1.87 1.87 0.85 (0.02) 0.24 0.28 (1.59)
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.42
EV/FCF
— (28.11) (28.11) (28.11) (0.74) 0.01 (0.18) (0.24) 0.41
Current Ratio
— 0.20 0.10 0.16 13.15 4.60 1.36 0.62 1.12
Net Debt/EBITDA
— (5.89) (4.13) 0.36 6.00 1.72 0.55 0.18 0.95
Debt/Equity
— (0.98) (0.97) (0.01) 0.11 0.00 0.00 0.00 0.00
ROE
— 25.99% 22.98% 18.61% (713.06%) (40.90%) (73.87%) (191.51%) (327.78%)
ROA
— (264.41%) (114.47%) (89.25%) (42.75%) (33.96%) (54.90%) (99.31%) (111.09%)
ROIC
— 0.00% 0.00% 0.00% (67.64%) (127.31%) (147.42%) (555.29%) 0.00%
Return on Tangible Assets
— 60.47% 33.62% 25.03% (29.41%) (65.59%) (478.94%) 598.30% (1,400.57%)
Average Days of Receivables
— 85.20 118.25 105.19 160.04 142.69 108.12 56.75 9.14
Earnings Yield
— (80.45%) (80.45%) (80.45%) (26.79%) (82.27%) (234.29%) (699.81%) (903.85%)
Free Cash Flow Yield
— (9.17%) (9.17%) (9.17%) (37.77%) (95.72%) (279.89%) (587.10%) (623.53%)
Free Cash Flow per Share
— (0.41) (4,668.50) (2,077.67) (2,359.57) (1,079.69) (933.82) (502.72) (45.54)
Book value per Share
— (2.81) (9,621.42) (13,420.75) 5,516.96 1,829.66 862.04 186.01 26.83
Free Cash Flow
— (2.69) (5.60) (2.49) (12.74) (11.98) (10.55) (8.95) (5.24)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.34
Other line items

Show all line items

Columns are period end dates